跳至主要内容
临床试验/KCT0008050
KCT0008050招募中未知

Postoperative hypofractionated intensity-modulated radiotherapy endometrial cancer: A prospective phase II trial (POHIM_EM trial)

Samsung Medical Center0 个研究点目标入组 92 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
入组人数
92

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
20(Year) 至 85(Year)(—)
性别
Female

入选标准

  • 1) Histologically diagnosed endometrioid type patient
  • 2) Patients who underwent hysterectomy and surgical staging
  • 3) Patient who corresponds to FIGO Stage III in surgical pathology examination
  • 4) Patients undergoing or planning to undergo systemic chemotherapy
  • 5) Adults between 20 and 80 years of age
  • 6) Whole body performance before participation in the study was ECOG 0-1
  • 7) When the patient voluntarily writes a consent form

排除标准

  • 1) Patients with distant metastases
  • 2) Patients who have previously received pelvic radiation therapy
  • 3) In case of untreated serious acute disease other than endometrial cancer
  • 4) In case of recurrence or recurrence within 5 years after diagnosis of other cancers except for thyroid cancer and skin cancer

研究者

相似试验